Mergers and acquisitions – Page 19
-
Business
DuPont sells car paints for $5bn
US investment group picks up 11,000 employees and $4 billion in annual sales
-
Business
Rockwood to pay C$720m for lithium firm
The chemical group has struck a deal to buy Talison, an Australian lithium producer with headquarters in Perth.
-
Business
Merck KGaA buys cell culture company
Biochrom makes cell culture media and buffer solutions
-
Business
BASF parts with paints
German and French parts of subsidiary Relius sold to wholesaler Prosol
-
Business
Pfizer to pay $250m for Nexium
AstraZeneca has sold rights to an over the counter version of its heartburn tablets
-
Business
Elan spins off drug discovery
The new company will be called Neotope Biosciences and focus on chronic degenerative diseases
-
Business
DSM buys into cattle supplements
The company has struck a EUR465 million deal to acquire Tortuga
-
Business
AkzoNobel sells ICI Pakistan
Yunus Brothers will pay $150 million for the recently restructured business
-
Business
GSK secures $3.6bn HGS deal
GlaxoSmithKline is set to buy Human Genome Sciences for $3.6 billion
-
Business
Bayer buys crop protection firm for $425m
Bayer has struck a deal to buy US pest control products firm AgraQuest
-
Business
BMS and AstraZeneca buy Amylin for $7bn
Two pharma giants have teamed up to buy US biotech Amylin, responsible for the Byetta and Bydureon anti-diabetes brands
-
Business
Pfizer to spin off animal health business
New company Zoetis should start independent trading by July 2013
-
Business
Takeda buys into Brazil for 540m reals
Multilab makes generics and over-the-counter branded products
-
Business
Solvay opens 200 employee Indian R&D centre
Belgian chemical company opens centre in Savli, Gujarat State
-
Business
AstraZeneca seeks to refill dry pipeline with gout drug
UK pharma giant splashes out $1.26 billion on US gout specialist Ardea Biosciences
-
Business
Dow partners with Oz university
Dow is to partner with the University of Queensland in Australia
-
Business
$500m for Ista
US eye drug company Bausch & Lomb has signed a cash deal to buy US drugmaker Ista Pharmaceuticals for $9.10 per share, equivalent to $500 million
-
Business
AbbVie emerges from Abbott split
US healthcare giant Abbott has renamed the branded drugs part of its business